These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 18835553)

  • 1. Soluble P-selectin as a marker of in vivo platelet activation.
    Ferroni P; Martini F; Riondino S; La Farina F; Magnapera A; Ciatti F; Guadagni F
    Clin Chim Acta; 2009 Jan; 399(1-2):88-91. PubMed ID: 18835553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased plasma levels of soluble CD40 ligand correlate with platelet activation markers and underline the need for standardized pre-analytical conditions.
    Riondino S; Martini F; La Farina F; Spila A; Guadagni F; Ferroni P
    Clin Biochem; 2010 May; 43(7-8):666-70. PubMed ID: 20060822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble CD40 ligand, soluble P-selectin, interleukin-6, and tissue factor in diabetes mellitus: relationships to cardiovascular disease and risk factor intervention.
    Lim HS; Blann AD; Lip GY
    Circulation; 2004 Jun; 109(21):2524-8. PubMed ID: 15136493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo platelet activation is responsible for enhanced vascular endothelial growth factor levels in hypertensive patients.
    Ferroni P; Martini F; D'Alessandro R; Magnapera A; Raparelli V; Scarno A; Davì G; Basili S; Guadagni F
    Clin Chim Acta; 2008 Feb; 388(1-2):33-7. PubMed ID: 18001701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of aspirin on intra-platelet vascular endothelial growth factor, angiopoietin-1, and p-selectin levels in hypertensive patients.
    Nadar S; Blann AD; Lip GY
    Am J Hypertens; 2006 Sep; 19(9):970-7; discussion 978. PubMed ID: 16942942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble P-selectin as a marker of platelet hyperactivity in patients with chronic obstructive pulmonary disease.
    Ferroni P; Basili S; Martini F; Vieri M; Labbadia G; Cordova C; Alessandri C; Gazzaniga PP
    J Investig Med; 2000 Jan; 48(1):21-7. PubMed ID: 10695266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble, platelet-bound, and total P-selectin as indices of platelet activation in congestive heart failure.
    Chung I; Choudhury A; Patel J; Lip GY
    Ann Med; 2009; 41(1):45-51. PubMed ID: 18618353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of plasma soluble P-selectin and von Willebrand factor as indices of platelet activation and endothelial damage/dysfunction in high-risk patients with hypertension: a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial.
    Varughese GI; Patel JV; Tomson J; Blann AD; Hughes EA; Lip GY
    J Intern Med; 2007 Apr; 261(4):384-91. PubMed ID: 17391113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of platelet P-selectin for remote testing of platelet function during treatment with clopidogrel and/or aspirin.
    Fox SC; May JA; Shah A; Neubert U; Heptinstall S
    Platelets; 2009 Jun; 20(4):250-9. PubMed ID: 19440925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antiplatelet effect of aspirin is reduced by proton pump inhibitors in patients with coronary artery disease.
    Würtz M; Grove EL; Kristensen SD; Hvas AM
    Heart; 2010 Mar; 96(5):368-71. PubMed ID: 19910291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet surface CD62P and CD63, mean platelet volume, and soluble/platelet P-selectin as indexes of platelet function in atrial fibrillation: a comparison of "healthy control subjects" and "disease control subjects" in sinus rhythm.
    Choudhury A; Chung I; Blann AD; Lip GY
    J Am Coll Cardiol; 2007 May; 49(19):1957-64. PubMed ID: 17498581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of homocysteine to markers of platelet and endothelial activation in "high risk" hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
    Spencer CG; Martin SC; Felmeden DC; Blann AD; Beevers GD; Lip GY
    Int J Cardiol; 2004 Apr; 94(2-3):293-300. PubMed ID: 15093996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of immunosuppressive drugs on platelet aggregation and soluble P-selectin levels in renal transplant patients.
    Sahin G; Akay OM; Kus E; Bal C; Yalcin AU; Gulbas Z
    Ren Fail; 2009; 31(2):111-7. PubMed ID: 19212907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular and platelet responses to aspirin in patients with coronary artery disease.
    Blann AD; Kuzniatsova N; Lip GY
    Eur J Clin Invest; 2013 Jan; 43(1):91-9. PubMed ID: 23198725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levels and value of soluble P-selectin following acute myocardial infarction: evaluating the link between soluble P-selectin levels and recruitment of circulating white blood cells and the marker for the rapid diagnosis of chest pain.
    Chiu CA; Wu CJ; Yang CH; Fang CY; Hsieh YK; Hang CL; Hung WC; Chen CJ; Chen SM; Yu TH; Yeh KH; Fu M; Yip HK
    Chang Gung Med J; 2005 Oct; 28(10):699-707. PubMed ID: 16382754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of reticulated platelets and platelet size heterogeneity on platelet activity after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease.
    Guthikonda S; Alviar CL; Vaduganathan M; Arikan M; Tellez A; DeLao T; Granada JF; Dong JF; Kleiman NS; Lev EI
    J Am Coll Cardiol; 2008 Aug; 52(9):743-9. PubMed ID: 18718422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble P selectin levels in chronic liver disease: relationship to disease severity.
    Vardareli E; Saricam T; Demirustu C; Gulbas Z
    Hepatogastroenterology; 2007 Mar; 54(74):466-9. PubMed ID: 17523300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The origin of P-selectin as a circulating plasma protein.
    Fijnheer R; Frijns CJ; Korteweg J; Rommes H; Peters JH; Sixma JJ; Nieuwenhuis HK
    Thromb Haemost; 1997 Jun; 77(6):1081-5. PubMed ID: 9241736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombin formation and platelet activation at the site of vascular injury in patients with coronary artery disease treated with clopidogrel combined with aspirin.
    Undas A; Stepień E; Branicka A; Wołkow P; Zmudka K; Tracz W
    Kardiol Pol; 2009 Jun; 67(6):591-8. PubMed ID: 19618315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of nebivolol on platelet activation in hypertensive patients: a comparative study with metoprolol.
    Celik T; Yuksel UC; Iyisoy A; Kursaklioglu H; Ozcan O; Kilic S; Ozmen N; Isik E
    Int J Cardiol; 2007 Mar; 116(2):206-11. PubMed ID: 16822563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.